Epia Neuro

Epia Neuro is a neural technology company based in San Francisco, building a minimally invasive brain-computer interface platform that detects neural intent and restores motor control for stroke survivors. Central to its work is a decoder system that interprets neural signals and converts them into precise digital commands in real time, continuously learning and refining accuracy for each patient. The technical scope spans neural decoding, neural signal sensing, neural stimulation, bioelectronics and wearable medical devices.

The company's proprietary brain sensing and stimulation interface captures neural signals without piercing the dura and is designed to be implanted in under an hour by any neurosurgeon. Alongside it sits a lightweight grip-assist wearable, built for daily life rather than the laboratory, developed through extensive collaboration with stroke survivors, advocates and clinicians. Epia Neuro states a commitment to restoring function and independence for people living with neurological conditions, and lists neurology applications including cognitive decline, Parkinson's disease and epilepsy among its areas.

The company is founder-led by Michel Maharbiz, who previously built iota Biosciences, acquired by Astellas.